Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,578.00
Bid: 1,578.00
Ask: 1,578.50
Change: -5.50 (-0.35%)
Spread: 0.50 (0.032%)
Open: 1,579.50
High: 1,583.50
Low: 1,575.50
Prev. Close: 1,583.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Big Pharma's bet on Big Data creates opportunities and risks

Tue, 26th Jan 2016 13:07

* Novartis plans to sell cloud-connected inhaler by 2019

* Part of companies' push into "Medical Internet of Things"

* Pharma and tech firms teaming up in hunt for Big Data

* But web-enabled devices present privacy and security risks

By John Miller

ZURICH, Jan 26 (Reuters) - Novartis wants everypuff of its emphysema drug Onbrez to go into the cloud.

The Swiss drugmaker has teamed up with U.S. technology firmQualcomm to develop an internet-connected inhaler thatcan send information about how often it is used to remotecomputer servers known as the cloud.

This kind of new medical technology is designed to allowpatients to keep track of their drug usage on their smartphonesor tablets and for their doctors to instantly access the dataover the web to monitor their condition.

It also creates a host of "Big Data" opportunities for thecompanies involved - with huge amounts of information about amedical condition and the efficacy of a drug or device beingwirelessly transmitted to a database from potentially thousands,even millions, of patients.

The potential scale of the so-called "Medical Internet ofThings" has not been lost on pharmaceutical and tech firmsaround the world, both big companies hunting growth and smallerones looking to provide bespoke products and services.

It has created unlikely alliances.

Novartis' domestic rival Roche has also teamed upwith Qualcomm and Danish diabetes drugmaker Novo Nordisk has partnered with IBM on cloud-linked deviceprojects, for example, while healthcare device maker Medtronic is working with a U.S. data-analytics firm Glooko.

GlaxoSmithKline, meanwhile, is in talks withQualcomm about a medical technology joint venture potentiallyworth up to $1 billion, according to people familiar with thematter.

However, with the opportunity comes risk.

Security experts warn that hacked medical information can beworth more than credit card details on the black market asfraudsters can use it to fake IDs to buy medical equipment ordrugs that can be resold, or file bogus insurance claims.

The U.S. Centers for Disease Control and Preventionestimates there are 35 million U.S. hospital discharges a year,a billion doctor and hospital visits and even moreprescriptions, much of which is stored in cloud databases.

CLOUD CONCERN

Now the "Medical Internet of Things" is introducing more andmore web-connected devices into the equation and pushing evenmore confidential patient data on to the cloud.

This is creating potential new opportunities for thievesseeking to penetrate medical companies' security where they maytarget names, birth dates, policy numbers, billing data and thediagnosis codes needed to obtain drugs, say experts.

"The weakest link tends to be the medical device itself,"said Rick Valencia, senior vice president of Qualcomm Life,Qualcomm's four-year-old healthcare unit. "They weren't designedwith the idea in mind that they would be going over the networkand the information would be residing in cloud infrastructure."

Medtronic, the world's largest standalone medical devicemaker, said in 2014 it lost patient records in separatecyberattacks at its diabetes business.

"The more information, the easier identity theft is and themore valuable the profiles that the hacker can sell to thirdparties," said Erik Vollebregt, a lawyer in Amsterdam whospecialises in medical device cybersecurity and privacy.

He said it could also be possible for criminals to hack intoweb-connected medical devices, and threaten the lives ofpatients, to blackmail the manufacturer.

Despite no documented patient-endangering hacks, the U.S.Food and Drug Administration warned last year an infusion pumpcould be vulnerable to attack and asked healthcare providers tostop using it.

SMART LENS

Novartis aims to have its inhaler for chronic lung disease,to be on the market by 2019. Other pharma-tech alliances includeAerocrine and Microsoft, which are workingtogether on a cloud project to analyse data from allergy andasthma patients.

Google is, meanwhile, working with Frenchdrugmaker Sanofi to collect and analyse informationfrom diabetes sufferers. The U.S. tech giant alsohas a partnership with Novartis to develop a smart contact lensthat can monitor diabetics' glucose levels.

All the companies involved in such projects say they aregoing to extreme lengths to protect patients' data from hackers.

Philips has turned to San Francisco-basedidentity-management software maker ForgeRock to keep data fromthe Dutch company's medical devices from falling into the wronghands.

Software security expert Marie Moe, of Norway's SINTEFscientific research foundation, said the wireless ports in thepacemaker that keeps her heart beating left it vulnerable tointrusion - but that she could not survive without the device.

"Wireless interfaces are a great benefit to certain patientgroups," she told Reuters. "But as a security researcher, I knowconnectivity also means vulnerability." (Additional reporting by Julie Steenhuysen in Chicago, JimFinkle in Boston and Ben Hirschler in London; Editing by PravinChar)

More News
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more
16 Apr 2024 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
16 Apr 2024 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
9 Apr 2024 11:45

Pfizer RSV shot meets goals in trial of high-risk adults under age 60

April 9 (Reuters) - Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.

Read more
8 Apr 2024 09:13

LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
4 Apr 2024 13:08

UK dividends calendar - next 7 days

Friday 5 April 
BBGI Global Infrastructure SAdividend payment date
Molten Ventures PLCdividend payment date
Pennon Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
Regional REIT Ltddividend payment date
Rights & Issues Investment Trust PLCdividend payment date
Sylvania Platinum Ltddividend payment date
Titon Holdings PLCdividend payment date
Triple Point Energy Transition PLCdividend payment date
Monday 8 April 
Alumasc Group PLCdividend payment date
LondonMetric Property PLCdividend payment date
Redrow PLCdividend payment date
Tuesday 9 April 
CT Global Managed Portfolio Trust PLCdividend payment date
Downing Strategic Micro-Cap Investment Trust PLCdividend payment date
Dunelm Group PLCspecial dividend payment date
Hays PLCdividend payment date
Renishaw PLCdividend payment date
Safestore Holdings PLCdividend payment date
Wednesday 10 April 
Assura PLCdividend payment date
Primorus Investments PLCspecial dividend payment date
Wilmington PLCdividend payment date
Thursday 11 April 
Amedeo Air Four Plus Ltdex-dividend payment date
Athelney Trust PLCdividend payment date
Aviva PLCex-dividend payment date
Balanced Commercial Property Trust Ltdex-dividend payment date
Barratt Developments PLCex-dividend payment date
Begbies Traynor Group PLCex-dividend payment date
Bioventix PLCex-dividend payment date
Blackfinch Spring VCT PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
Caledonia Mining Corpex-dividend payment date
Capital & Regional PLCex-dividend payment date
Chesnara PLCex-dividend payment date
Colefax Group PLCdividend payment date
CT Private Equity Trust PLCex-dividend payment date
Downing Strategic Micro-Cap Investements Trust PLCex-dividend payment date
Driver Group PLCdividend payment date
F&C Investment Trust PLCex-dividend payment date
Foxtons Group PLCex-dividend payment date
Grafton Group PLCex-dividend payment date
GSK PLCdividend payment date
Harbour Energy PLCex-dividend payment date
Hargreaves Services PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
Hunting PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
International Personal Finance PLCex-dividend payment date
International Public Partnerships Ltdex-dividend payment date
ITV PLCex-dividend payment date
Johnson Service Group PLCex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Just Group PLCex-dividend payment date
Kenmare Resources PLCex-dividend payment date
Kerry Group PLCex-dividend payment date
Kings Arms Yard VCT PLCex-dividend payment date
Law Debenture Corp PLCdividend payment date
Lloyds Banking Group PLCex-dividend payment date
Lowland Investment Cos PLCex-dividend payment date
Luceco PLCex-dividend payment date
Man Group PLCex-dividend payment date
Manchester & London Investement Trust PLCex-dividend payment date
Marble Point Loan Financing Ltdex-dividend payment date
Mercantile Investment Trust PLCex-dividend payment date
Mobius Investment Trust PLCex-dividend payment date
MTI Wireless Edge Ltddividend payment date
North American Income Trust PLCex-dividend payment date
Northamber PLCex-dividend payment date
Octopus Apollo VCT PLCex-dividend payment date
Phoenix Group Holdings PLCex-dividend payment date
Reckitt Benckiser Group PLCex-dividend payment date
Ricardo PLCdividend payment date
Savills PLCex-dividend payment date
Schroder Asian Total Return Investment Cos PLCex-dividend payment date
Schroder European Real Estate Investment Trust PLCex-dividend payment date
Scottish American Investment Cos PLCdividend payment date
Smurfit Kappa Group PLCex-dividend payment date
Softcat PLCex-dividend payment date
Somero Enterprises Incex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Synectics PLCex-dividend payment date
TP ICAP Group PLCex-dividend payment date
Trifast PLCdividend payment date
TT Electronics PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.